Cargando…
Preliminary results of an intravitreal dexamethasone implant (Ozurdex®) in patients with persistent diabetic macular edema
BACKGROUND: To evaluate the efficacy and safety of an intravitreal dexamethasone implant (Ozurdex®; Allergan Inc, Irvine, CA, USA) in patients with persistent diabetic macular edema (DME) over a 6-month follow-up period. METHODS: Seventeen patients (20 eyes) affected by DME were selected. The mean a...
Autores principales: | Pacella, Elena, Vestri, Anna Rita, Muscella, Roberto, Carbotti, Maria Rosaria, Castellucci, Massimo, Coi, Luigi, Turchetti, Paolo, Pacella, Fernanda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3720664/ https://www.ncbi.nlm.nih.gov/pubmed/23901252 http://dx.doi.org/10.2147/OPTH.S48364 |
Ejemplares similares
-
Intravitreal Injection of Ozurdex(®) Implant in Patients with Persistent Diabetic Macular Edema, with Six-Month Follow-Up
por: Pacella, Fernanda, et al.
Publicado: (2016) -
Dorzolamide Chlorhydrate Versus Acetazolamide in the Management of Chronic Macular Edema in Patients with Retinitis Pigmentosa: Description of Three Case Reports
por: Pacella, Elena, et al.
Publicado: (2014) -
Intravitreal Dexamethasone Implant (Ozurdex) for Refractory Macular Edema Secondary to Retinitis Pigmentosa
por: Örnek, Nurgül, et al.
Publicado: (2016) -
Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema
por: Castro-Navarro, Verónica, et al.
Publicado: (2019) -
Dexamethasone Intravitreal Implant (Ozurdex) for Long-Term Macular Edema after Epiretinal Membrane Peeling Surgery
por: Chang, Yo-Chen, et al.
Publicado: (2018)